Covid-19 News and Discussions


August 7, 2024

3 min read

COVID-Positive Olympic Athletes Are Still Competing​

Several athletes at the Paris 2024 Olympic Games have come down with COVID, but they are still allowed to compete

By Saima S. Iqbal

Underwater view of three swimmers competing in lanes

Adam Peaty of Team Great Britain competes in the Men’s 100m Breaststroke Final on July 28 at the Olympic Games Paris 2024 in Nanterre, France. Peaty is among several athletes who have tested positive for COVID.

Around 11,000 of the world’s top athletes have gathered in Paris to compete in the 2024 Summer Olympics. In the past two weeks, at least 19 have tested positive for COVID. Many of these athletes compete for Australia or are in aquatic sports. The current count includes, for instance, British swimmer Adam Peaty and Australian swimmers Lani Pallister and Zac Stubblety-Cook. Although only a small fraction of the competitors are known to be infectious, some experts fear a wider outbreak; in the absence of testing requirements, it’s possible many more participants could harbor the COVID-causing virus SARS-CoV-2.

The Tokyo 2020 Summer Olympics and Beijing 2022 Winter Olympics implemented strict rules to limit the spread of COVID, including regular testing, social distancing and near-constant mask wearing. The Paris 2024 Olympic Games, by contrast, aim at a return to normalcy. It’s not just that thousands of spectators now fill the stands, where they were once banned. The Paris Games also drop all previous COVID protocols, instead approaching the disease like other respiratory illnesses such as the common cold or the flu: officials now allow athletes and teams to determine for themselves how to prevent or respond to infection.

Athletes no longer undergo daily testing or frequent temperature checks. Players who feel ill are encouraged—though not required—to wear masks, wash their hands and avoid close contact with others. The Olympic Village has single rooms available for athletes who test positive for COVID, and certain countries, such as the U.S., provide separate transportation for sick participants. Infected athletes may still train and compete in events—and so far many have. A handful have dropped out of certain events to save their energy for others, and one athlete, German decathlete Manuel Eitel, has left the games altogether.

SARS-CoV-2 still has the potential to disrupt the remaining events, especially if entire teams catch it. “It makes sense to be more aware of [the virus] moving forward,” says Peter Chin-Hong, an infectious disease doctor at UCSF Health. “We still have a ways to go in the Olympics.”

As a large, congregate setting full of panting and shouting people, the Olympic Village provides “picture-perfect ways to spread” respiratory illness, Chin-Hong notes. But unlike the flu or the common cold, COVID is now surging across the U.S. and many regions of Europe, thanks in part to new, more transmissible strains of SARS-CoV-2. Athletes who compete in contact sports or in sites with poor ventilation may be at the highest risk for infection, but all athletes frequent danger zones such as the locker room or the dining hall.

COVID also takes a more serious toll on the body than either colds or the flu, Chin-Hong says. While most Olympic athletes are healthy and have access to cutting-edge medications, young people sometimes display mixed responses to infection. Athletes with comorbidities, such as U.S. gymnast Sunisa Lee, who lives with kidney disease, or U.S. swimmer Katie Ledecky, who has postural orthostatic tachycardia syndrome, may be more vulnerable than others. And even mild COVID symptoms can impair a person’s performance.

One 2024 study of several hundred German athletes found that elite athletes infected with COVID had milder infections than nonelite ones. But more than half of these elite athletes said their symptoms—which included headaches, cough, fever and sore throat—hampered their training for two to four weeks. And several months later 10 percent of them reported trouble concentrating and a drop in their performance. A 2023 survey of more than 800 elite aquatic athletes showed that 16 percent of those infected had no symptoms; 51 percent had mild symptoms; and 27 percent had moderate ones, with 10 percent of athletes developing long-term symptoms such as fatigue and shortness of breath.

Infectious competitors can also sicken coaches and staff, who tend to be older and therefore at greater risk for serious illness. Several team members with sick athletes are now wearing masks, the Guardian reported.

Officials from the Paris Games told Scientific American that they are working closely with France’s Ministry of Health to monitor further spread of SARS-CoV-2. The week the games began, French health minister Frédérick Valletoux reassured the public that he had little reason to fear an outbreak. COVID cases in the country have risen over the summer, but they remain at “a low rumble,” he said in a July 25 broadcast interview.

On August 6 a representative of the World Health Organization stressed in a United Nations press briefing that rates of COVID have increased all over the globe in the past few weeks, demanding further vigilance. In Europe more than 20 percent of COVID tests have been positive in recent weeks.
 

Respect Thoses Who Choose To Mask For A Covid Pandemic​


 

Over 40 Olympic athletes test positive for COVID-19 amid resurgence​


 

Subtle Rise In Covid-Related Hospitalizations | August 6, 2024 | News 19 at 5 p.m.​


 

Air Canada profits falls as Covid-19 recovery drags on​


 

COVID-19, Flu, and RSV: A 2024 Update from the CDC​


 

Preparing for back to school with COVID​


 

Contra Costa County Health Department recommends masks during COVID surge | KTVU​


 

COVID-19: German gov't suffers defeat in 'face mask scandal'​

Sabine Kinkartz
07/23/2024July 23, 2024

At the start of the COVID-19 pandemic, German Health Minister Jens Spahn offered to pay high prices for protective masks. He later tried to backtrack, but a court has now ruled the government will have to foot the bill.

CDU politician Jens Spahn was Federal Health Minister from 2018 to 2021Image: Kay Nietfeld/dpa/picture alliance
ADVERTISEMENT

Germany's government has received some bad news at a time of tricky budget negotiations.

The Higher Regional Court in Cologne has ruled in favor of a supplier of protective face masks, which the Federal Health Ministry ordered in 2020 at the start of the COVID-19 pandemic, but later refused to accept or pay for. The judges ruled that the ministry should pay €85 million ($92 million), plus €33 million in default interest.

The ruling may well have a knock-on effect, as another 100 similar lawsuits are pending in court. If the Health Ministry is defeated in these cases, it could face a record loss of €2.3 billion in total.

The mask purchases are already considered one of the biggest tax wastage scandals in the history of the Federal Republic of Germany.
A look back: In March 2020, the world was literally overrun by COVID-19. A vaccine was still months away, and medical protective gear was dwindling. Respiratory masks with the FFP2, KN95 or N95 standard, which are supposed to provide reliable protection against the virus, were in desperately short supply and there was a worldwide rush to stock up.

"China, the producer of around 80% of such masks at the time, was in lockdown and had stopped exports," recalled Simone Borchardt, a lawmaker for the center-right Christian Democratic Union (CDU) which led the government at the time. "In Germany, we even developed guidelines on how we could use masks several times and whether they could be washed, that's how crazy it was back then," Borchardt told the lower house of parliament, the Bundestag, during a debate in June.

In this situation, then Health Minister Jens Spahn decided to procure masks in a sort of "open house" procedure. In this process, the relevant government body signs contracts with all interested companies so every provider gets a chance.

Spahn's thinking was that in the global competition for masks, he only had to set the price high enough to make sure Germany would get the goods. Contrary to the recommendation of his ministry officials, who considered a price of €3 (about $3.25 today) per mask to be appropriate, Spahn set the price at €4.50 for FFP2 masks, and at €0.60 for surgical masks. The response exceeded expectations and, in the end, the ministry found itself having placed orders for 5.7 billion masks.

"The price was set far too high," said Martina Stamm-Fibich, from the center-left Social Democratic Party (SPD), which was the junior coalition partner to Spahn's CDU at the time and currently heads the government of Chancellor Olaf Scholz. "In my view, this already raises the question of how it was possible to calculate prices without taking market developments into account and who bears the political responsibility for this," Stamm-Fibich said in the Bundestag.

What is the environmental impact of FFP2 face masks?​


Four years later, Spahn is now on the defensive: "With the knowledge of today, I would make some decisions differently, without a doubt," he admitted in the debate. "And yes, in hindsight I cannot recommend the 'open house procedure' in such a situation."

However, he argued, he had to make decisions quickly in desperate times: human lives were at stake and medical staff were demanding protection.

"We procured masks. Were they expensive? Yes. Was it chaotic at times? Yes. It was the same for every country in the world," Spahn said. "I don't recall anyone warning at the time to make sure the price isn't too high, but I know a lot of people who said: 'Get masks at any price'."

Did the Health Ministry miscalculate?​

The Health Ministry's calculation was that with 5 million health care workers needing two masks a day, more than 3 billion masks would be needed each year.

However, in the end, only 1.7 billion of the ordered masks were distributed. As early as 2023, 1.2 billion protective masks were destroyed because their expiry date had passed.

What Spahn hasn't said is that the Health Ministry must have come to the conclusion early on that it had miscalculated. The "open house" procedure was abruptly ended in May 2020 and ministry officials were trying to find ways to get out of as many contracts as possible.

An opportunity arose when some companies failed to deliver the expected quality. In these cases, the ministry unilaterally withdrew from the purchase contract. The same happened to suppliers who were unable to deliver on time, or only provided a part of the masks on the agreed date. The purchase contracts referred to a "fixed deal," claiming all contractual obligations would cease after the delivery date had passed.

Germany faces budget crisis after court ruling​


However, it's precisely this clause that the Higher Regional Court in Cologne has now declared invalid. The judges found that suppliers had been put at an "unreasonable disadvantage" and the ministry should have been more flexible and set a shorter subsequent deadline.

The Health Ministry now wants to have the case clarified at the highest level by the Federal Court of Justice. If the court rejects the case, the Cologne ruling will become legally binding and is likely to have an impact on the other court proceedings — with the corresponding financial consequences.

Ongoing reappraisal of COVID-19 measures​

Beyond the legal struggle, the political debate also continues — and it goes far beyond the prices of medical masks. Were the government's COVID measures, with their deep and far-reaching encroachments on fundamental rights, justified? What lessons can be learned from the pandemic, and what should be done differently in the future?

However, the parties of the ruling center-left coalition government — the SPD, Greens and the neoliberal Free Democrats (FDP) — have not yet been able to agree on what form a reappraisal would be appropriate. All three parties are in favor of a citizens' council. The Greens and the FDP are also pushing for the establishment of a commission of inquiry in the Bundestag, allowing lawmakers and experts to be heard and make recommendations for further procedures.

This article was originally written in German.
 

Von der Leyen’s second term as EU president could be in jeopardy after Covid vaccine ruling​

Ursula von der Leyen's attempt for a second term as European Commission chief has encountered a significant setback after a top EU court determined she was not sufficiently transparent with the public regarding Covid-19 vaccine contracts.

Issued on: 18/07/2024 - 12:17

2 min
European Commission President Ursula von der Leyen walks on to the stage during the opening ceremony of the recovery conference in Berlin, Germany, June 11, 2024.
European Commission President Ursula von der Leyen walks on to the stage during the opening ceremony of the recovery conference in Berlin, Germany, June 11, 2024. © Ebrahim Noroozi / AP
By:Jan van der Made with RFI
ADVERTISING

This after the EU's Court of Justice ruled against the Commission’s decision to redact large parts of the contracts before making them available, just 24 hour before the European Parliament will vote on the exension of Von der Leyen’s mandate as the EU's President.

According to a press release published by the court on Wednesday, the EU Commission, led by Von der Leyen "did not give the public sufficiently wide access to the purchase agreements for Covid-19 vaccines"

The statement says that in 2020 and 2021, the EU Commission concluded purchase agreements for Covid-19 vaccines with "some pharmaceutical undertakings" resulting in the quick release of some €2.7 billion for the purchase of "more than one billion doses of vaccine."

The commission failed to show how divulging indemnification details would harm the commercial interests of the pharmaceutical groups supplying the vaccines, the EU General Court ruled.




It also failed a "public interest" test by keeping secret the names of the EU officials involved, the court said.

Politico reports that when EP members of parliament requested access to the contracts, they appeared to be heavily redacted. When total access was refused, Green MEPs then took the Commission to court over the refusal.

The issue may influence MEPs voting for the extension of Von der Leyen's second term as EU Commission President.

She needs 361 of the 720 MEP votes to secure her job.

Complex rules​

If approved by MEPs on Thursday, Ursula von der Leyen will serve as the President of the European Commission for the next five years.

Under the European Union’s complex rules and regulations, party blocs within the European Parliament can nominate candidates.

On 23 May, five candidates - Walter Baier (European Left), Sandro Gozi (Renew Europe Now), Ursula von der Leyen (European People’s Party), Terry Reintke (European Greens), and Nicholas Schmit (Party of European Socialists) - participated in a debate broadcast by Eurovision.



Eurovision debate between candidates for the position of President of the European Union, featuring Ursula von der Leyen, Walter Baier, Sandro Gozi,Terry Reintke,  and Nicholas Schmit.
Eurovision debate between candidates for the position of President of the European Union, featuring Ursula von der Leyen, Walter Baier, Sandro Gozi,Terry Reintke, and Nicholas Schmit. © Screengrab Eurovision debate
Two parties, the European Conservatives and Reformists and Identity and Democracy, did not nominate lead candidates and were not eligible to take part in the debate.

During an EU Council summit in Brussels at the end of May, European leaders then agreed to back a second term for Von der Leyen.

They also picked former Portuguese Premier Antonio Costa as the future chair of their European Council meetings and choose Estonian Prime Minister Kaja Kallas as the next EU foreign policy chief.

In 2019, 733 members of the European Parliament elected Von der Leyen with 383 votes in favour, 327 against and 22 abstentions. The term is five years.

According to the European Parliament's website, If the candidate does not obtain the required majority, the President "shall invite the European Council to propose a new candidate within one month for election in accordance with the same procedure."
 

COVID-19 cases beginning to rise in Manitoba: Roussin​



bio-kayla-1-4828723.jpg

Kayla Rosen
CTVNewsWinnipeg.ca Editorial Producer
Follow |Contact
Published Aug. 7, 2024 2:03 p.m. EDT

Though summer doesn’t seem like the usual time to catch a cold or virus, COVID-19 is currently circulating in Manitoba and cases are beginning to rise.

With some provinces seeing a surge in COVID-19 cases, Manitoba’s chief provincial public health officer Dr. Brent Roussin said the province has been seeing an upward trend in transmission.

However, he said, the numbers are nowhere near what is typically seen in peak season.

“COVID has just not declared itself as a true seasonal virus yet,” he said in an interview on Tuesday.

“We’ve continued to see it all year round, albeit at much lower levels during the spring and summer.”

Roussin said there are several different strains circulating in the province, noting that symptoms include a runny nose, cough, sore throat and flu-like illness.

He reminds Manitobans that if you’re feeling sick or symptomatic, it’s best to stay at home.

“That’s the most likely time we’re going to transmit these viruses is when we’re showing symptoms,” he said.

“So if we can stay home when we’re ill, we’re reducing the risk of transmission.”

Roussin added that this fall the province plans to have a robust vaccination campaign against COVID and influenza. He said, for the most part, fall will be the best time to get vaccinated as there will be a new formulation.

“We’re encouraging Manitobans to start thinking about when those are available, getting both of those shots when you’re eligible,” he said.

Roussin said at this point Manitoba is not seeing an increase in severe outcomes and hospital admissions, but it’s something the province needs to be aware of.

- With files from CTV’s Rachel Lagace.
 

Covid tests on shelves, but demand low in Manitoba


Aaron Epp
By: Aaron Epp Posted: 5:58 PM CDT Wednesday, Aug. 7, 2024

The Manitoba government has distributed 1.1 million COVID-19 rapid antigen test kits this year, but demand for them is low.

The province confirmed Wednesday it is still distributing rapid tests to pharmacies, doctors’ offices and retail locations. However, due to low demand from the public, many locations have not ordered tests for a significant period of time.

As of July 17, Manitoba had 443,000 rapid test kits in stock.

Testing is only recommended for people who are at high risk of serious outcomes so they can receive early treatment, such as antivirals.

Manitobans can contact their health care provider if they are at high risk for severe disease to determine whether testing (PCR or rapid test) is recommended.

While rapid tests are only recommended for people who are at high risk of serious outcomes, the province said it recognizes that anyone with symptoms may wish to use a rapid test.

The province’s website includes a map of locations that have agreed to distribute rapid tests. If a location indicates it no longer wishes to distribute tests, it is removed from the map.

“At present, no locations have said that they no longer wish to distribute tests, although many locations have not ordered tests in a significant period of time,” a provincial spokesperson said. “The public is still advised to contact locations directly to ensure stock.”

Recent wastewater data showed high concentrations of the virus in south Winnipeg and the West End, while levels were moderate across the province.

“We’ve continued to see it all year round, albeit at much lower levels during the spring and summer,” Dr. Brent Roussin, Manitoba’s chief provincial health officer, told a Winnipeg media outlet this week.

Roussin reminded Manitobans if they feel sick or symptomatic, it’s best to stay home. Symptoms include a runny nose, cough, sore throat and flu-like illness.

Meanwhile, an 81-year-old Winnipeg woman said she was surprised when she sought a COVID-19 booster at her local pharmacy and then her doctor’s office and neither had any available.

Faith Johnston is planning a trip to Vancouver to visit family next week and was reminded that a booster might be a good idea after reading a Free Press article last week.

The article included a quote from epidemiologist Cynthia Carr, who said that if it’s been five or six months since your last shot, you are not optimally protected.

“It’s possible there are some (boosters) out there, but it doesn’t seem to be very accessible,” Johnston said.
 

Summer covid surge hits at least 84 countries and continues to climb​

Dozens of athletes at the Paris Olympics have tested positive for the coronavirus.

Members of the Australian swim team wear masks while attending competition at the Paris Games. (Dave Hunt/EPA-EFE/Shutterstock)
By Sabrina Malhi
,
Lizette Ortega
and
Dan Keating
August 7, 2024 at 5:00 p.m. EDT

A summer covid wave — and the accompanying fevers, coughs and general misery — continues to wash over the Americas and parts of Asia and Europe, including the Paris Olympics, offering the latest evidence that the coronavirus moves in ways distinct from other respiratory ailments.

The World Health Organization said this week that the virus is increasing in at least 84 countries despite perceptions that the pathogen is a remnant of the past. Disease trackers sounded alarms that diminished testing and low vaccination rates could provide fertile terrain for more dangerous viral variants to take hold.

“Covid-19 is still very much with us,” Maria Van Kerkhove, a WHO epidemiologist, said at a news briefing Tuesday.

At least 40 athletes have tested positive for the coronavirus and other respiratory illnesses, suggesting that the virus may not exhibit the same seasonal patterns as the common cold, flu and respiratory syncytial virus — widely known as RSV — which tend to strike during cold-weather months.

The uptick has sparked concerns about efforts to prevent the spread of the disease at the Olympics. Testing and reporting vary by team, and the lack of streamlined efforts to minimize the spread highlights stark difference between the Paris Games and the Tokyo Olympics held in 2021.

At the Tokyo Games, spectators were barred and people were required to take two coronavirus tests on two separate days within 96 hours of their flight to Japan. Upon arrival in Japan, further testing was conducted at the airport. This is a sharp contrast from the Paris Games, where people who tested positive are competing, there are no testing requirements, and spectators are back in attendance.

The rise in global cases comes during pandemic fatigue and a decline in testing for the virus and reporting of cases. As a result, health agencies confront significant challenges in monitoring and understanding the virus’s impact.

“I am concerned,” Van Kerkhove said. “With such low [vaccine] coverage and with such large circulation, if we were to have a variant that would be more severe, then the susceptibility of the at-risk populations to develop severe disease is huge.”
Wastewater analysis offers one of the main methods for gaining insight into infection levels. Van Kerkhove said circulation rates are estimated to be two to 20 times higher than baseline levels established for comparison purposes at each testing station.

At the peak of the omicron variant in January 2022, the concentration of the coronavirus in wastewater samples peaked at 23 times higher than earlier levels, according to the Centers for Disease Control and Prevention. Levels were just barely above baseline at most stations nationally in April and May, but they have risen in the past two months to seven times the baseline concentration — a considerable increase but far below the rate of the nation’s largest outbreaks.

With the increase, public health experts worry that more severe variants of the coronavirus could emerge heading into fall and winter — and with waning vaccination rates, people with a higher risk of severe infection could face more dangerous outcomes.
Elevated infection rates during summer months in the Northern Hemisphere deviate from the typical pattern of respiratory viruses, which usually thrive during the fall and winter. While current hospitalization rates are lower than peak levels during the pandemic, WHO is calling on governments to bolster vaccination initiatives for high-risk groups.

“The virus continues to confound me in terms of what it’s doing and how it’s bucking the trends of seasonal patterns of respiratory illness,” said Scott Roberts, an infectious-disease physician at Yale School of Medicine.

Roberts suggests that a vaccine twice a year to address the surges might be an important step in minimizing summer spread.
“I certainly haven’t seen anyone doing mitigation strategies, such as masking and whatnot, in the summer months,” Roberts said. “So, maybe we need to rethink the timing of this virus and stop treating it like a once-every-year virus the way we do with flu.”
As of July 21, Russia had the highest number of cases worldwide, but the United States had the most reported number of deaths, according to WHO data.

“The number of cases is up, but the quality in terms of deadliness is not,” said Otto Yang, an associate chief of infectious diseases at UCLA’s David Geffen School of Medicine. “Still, a lot of people are still dying, and it is still having a big impact on society, so we should still be taking this seriously.”

Otto said another concern is that the virus could become more deadly because it’s continuing to mutate, and data shows an increased risk of complications with each subsequent coronavirus infection someone endures. He cautioned that a mutating virus could also pose a threat to treatments.
As a virus spreads, it can mutate to make itself stronger. And as it mutates, it can figure out how to evade disease-fighting antibodies to better infect people and to survive longer in aerosol and droplet form, according to Andrew Pekosz, a professor of microbiology at Johns Hopkins University who studies how respiratory viruses, such as the coronavirus, replicate.

“The more opportunities we give the virus to mutate, the more likely that some of these mutations will emerge,” Pekosz said.

Covid in the U.S.​


A family wears masks while visiting the Natural History Museum in D.C. in May. (Pete Voelker for The Washington Post)
As of July 27, the highest rate of covid in U.S. emergency rooms was found among children 11 and younger, narrowly surpassing the incidence in adults 75 and older.

Nancy Foster, vice president for quality and patient safety policy at the American Hospital Association, said some hospitals in California have reported seeing covid admissions higher than expected, with patients staying in the hospital longer than during recent waves. But the bigger concern for hospitals lies in the months ahead as the United States enters respiratory viral season, she said.

“That’s the worry I hear most from hospitals is [that if] we don’t get this in hand, if people don’t take their vaccination either for flu or RSV or covid, then we could see large influxes of patients again, and that’s certainly something we’d like to avoid,” Foster said.
Despite the surge in cases this summer, some regions have instituted anti-mask policies. North Carolina passed an anti-masking bill in June, and a county on Long Island followed suit Monday. Those bans include exceptions for medical mask-wearing, but critics worry people trying to avoid covid could still be harassed.

Pekosz said the United States is seeing a “swarm of variants” that have picked up similar mutations, which could indicate that the virus has a limited number of ways to evolve.

“We don’t have any data that suggests that the variants that are circulating now cause more severe disease,” he said.
Monitoring coronavirus cases that result in hospitalization and death is straightforward, but accurately tracking the overall number of cases poses a greater challenge because many people opt out of testing and medical care after contracting the virus.
The absence of comprehensive data on total coronavirus cases hinders the assessment of variant severity, because researchers cannot determine the proportion of cases that lead to hospitalizations or deaths.

Fenit Nirappil contributed to this report.
 
Last edited:
@Sharma Ji


New Study Confirms: Covid Injections Cause DEBILITATING Neurological Disorders​

A bombshell new study has confirmed that surging cases of several once-rare forms of “debilitating neurological disorders” are being caused by Covid mRNA shots.​


LIONESS OF JUDAH MINISTRY
AUG 07, 2024

Exposing The Darkness is a reader-supported publication. To support my work, please consider becoming a paid subscriber.

Subscribe


One-time or recurring donations can be made through Ko-Fi:



By Frank Bergman August 7, 2024

A bombshell new study has confirmed that surging cases of several once-rare forms of “debilitating neurological disorders” are being caused by Covid mRNA shots.

The discovery was made by an international group of neurology-focused researchers.

The team, made up of leading researchers in the United States and Kenya, sought to investigate the links between Covid mRNA injections and recent spikes in reports of autoimmune encephalitis (AE), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).

All three are described as “complex and debilitating neurological disorders.”

For the study, the researchers used data from the U.S. Centers for Disease Control and Prevention’s (CDC) Vaccine Adverse Event Reporting System (VAERS).

VAERS has recorded surging reports of AE, NMOSD, and MOGAD since the Covid mRNA injections were rolled out for public use in early 2021.

As part of this investigation, the authors sought to better understand any potential relationship between vaccinations and the incidence of NMOSD, AE, and MOGAD—mindful of possible risk factors, the authors used multivariate logistic regressions applying to age, sex, type of vaccine, and previous history of autoimmune diseases.

The study team was led by Professors Maria Garcia-Dominguez and Bahadar S. Srichawla, both at the University of Massachusetts Chan Medical School, Department of Neurology.

The study’s paper was published in the MedRxiv medical journal.

The researchers concluded from this study that a majority of the vaccine-induced NMOSD, AE, and MOGAD cases were caused by Covid mRNA injections.

Most of the cases analyzed during the study resulted in hospitalization, the researchers note.

The authors of this study were affiliated with the following:

  • University of Massachusetts Chan Medical School
  • William Carey University College of Osteopathic Medicine
  • College of Health Sciences, University of Nairobi
  • Faculty of Medicine, Nnamdi Azikiwe University College of Health Sciences
  • University of California, Berkeley
For the study, the researchers analyzed a total of 161 cases of neurological disorders that had been reported to VAERS.

Out of 161 cases, the authors found the following:

  • 72 cases of NMOSD
  • 82 cases of AE
  • 7 cases of MOGAD
Of the cases analyzed by the study, the researchers found that an alarming number were found to have been caused by the Covid shots.

For NMOSD, 19 out of the 72 cases were caused by mRNA injections or 26.3% of the reports.

The study found that Covid shots caused 43 out of the 82 cases of AE, equal to 52.4%.

The injections were responsible for 6 out of the 7 cases of MOGAD, or 85.7%.

According to the researchers, Covid mRNA shots were significantly associated with hospitalization for those with NMOSD.

The Covid shots have been implicated in the triggering of various autoimmune conditions with and without central nervous system involvement, the researchers note.

In the study’s paper, the researchers explain that adjuvants in vaccines are supposed to enhance autoimmune responses by creating a more robust immune activation.

However, while these adjuvants are meant to help bolster response, the neurologist authors acknowledge they can “inadvertently escalate autoimmunity risks in genetically susceptible individuals.”

They warn that the evidence shows that Covid mRNA injections appeared to be initiating or exacerbating autoimmune processes such as NMOSD and AE.

The neurologists offer some examples: with “NMOSD, disrupted Tregs could not control autoimmunity against aquaporin 4, leading to demyelination and neurological symptoms, while in AE, insufficient Treg activity could allow unchecked inflammation within the central nervous system, resulting in encephalitic symptoms.”

According to the findings of the study, “the complex interaction between vaccine components and the immune system” can create a situation where the Covid shots “potentially initiate neurological autoimmune disorders.”

This troubling study comes after a group of prominent Italian scientists recently raised the alarm after discovering a new “neurological emergency” that is emerging among those who have been “vaccinated” with Covid mRNA shots.

The warning was issued by scientists at the University of Chieti-Pescara in Chieti, Italy, as Slay News reported last week.

They report that two cases of deadly Status Epilepticus (SE) have now been confirmed to have been caused by Covid mRNA injections.

In a peer-reviewed study, published in the European Journal of Epilepsy, the scientists revealed that SE, a dangerous condition in which epileptic fits follow one another without recovery of consciousness between them, has a mortality rate of 20 percent.

They note that cases of SE have surged since February 2021, when the worldwide vaccination campaign was launched to supposedly tackle the COVID-19 pandemic.

The Italian authors of this study have identified several possible vaccine-related adverse events, including neurological manifestations.

Moreover, SE emerges in the literature as an emergent condition in COVID-19-vaccinated individuals.

The authors of the study’s paper confirm that both cases of SE that they analyzed were caused by Covid mRNA shots.

They are now calling for more research to better understand the link between Covid injections and status epilepticus.

Source: slaynews.com
 

Users who are viewing this thread

Back
Top